| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.38B | 26.83B | 22.53B | 21.90B | 19.38B | 12.00B |
| Gross Profit | 10.55B | 8.77B | 5.44B | 3.85B | 4.04B | 2.84B |
| EBITDA | 1.01B | 1.19B | -1.67B | -3.82B | -3.95B | -1.07B |
| Net Income | 220.34M | -1.35B | -4.82B | -7.51B | -6.81B | -3.01B |
Balance Sheet | ||||||
| Total Assets | 38.79B | 32.70B | 33.16B | 41.83B | 52.05B | 23.87B |
| Cash, Cash Equivalents and Short-Term Investments | 22.29B | 16.54B | 15.04B | 19.56B | 30.22B | 12.76B |
| Total Debt | 9.82B | 5.15B | 7.64B | 15.54B | 19.22B | 8.59B |
| Total Liabilities | 24.64B | 18.59B | 18.75B | 26.59B | 30.34B | 16.08B |
| Stockholders Equity | 14.16B | 14.11B | 14.39B | 15.24B | 21.70B | 7.60B |
Cash Flow | ||||||
| Free Cash Flow | 3.29B | 4.26B | -1.06B | -6.65B | -6.33B | -1.49B |
| Operating Cash Flow | 3.29B | 6.01B | 266.62M | -3.91B | -2.65B | 753.10M |
| Investing Cash Flow | -7.19B | -138.09M | 1.76B | 10.61B | -24.58B | -8.91B |
| Financing Cash Flow | 4.30B | -2.83B | -5.07B | -4.35B | 30.39B | 8.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$4.16B | 7.47 | 17.91% | 3.82% | 4.02% | -23.98% | |
73 Outperform | HK$536.69B | 18.22 | 24.72% | 2.22% | 5.45% | 32.55% | |
69 Neutral | HK$29.95B | 18.73 | 49.47% | 1.18% | 51.87% | 4031.49% | |
64 Neutral | HK$74.37B | 62.43 | 8.04% | ― | 16.59% | ― | |
62 Neutral | HK$31.53B | 9.26 | 8.02% | 0.48% | -0.11% | 12.80% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
39 Underperform | HK$939.30M | 10.57 | -27.26% | ― | -17.65% | 48.05% |